Your browser doesn't support javascript.
loading
A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.
Sahai, Vaibhav; Griffith, Kent A; Beg, Muhammad S; Shaib, Walid L; Mahalingam, Devalingam; Zhen, David B; Deming, Dustin A; Zalupski, Mark M.
Afiliação
  • Sahai V; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Griffith KA; Center for Cancer Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
  • Beg MS; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas, Southwestern, Dallas, Texas, USA.
  • Shaib WL; Department of Hematology and Oncology, Emory University, Atlanta, Georgia, USA.
  • Mahalingam D; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Zhen DB; Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, Washington, USA.
  • Deming DA; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
  • Zalupski MM; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Cancer ; 128(19): 3523-3530, 2022 10 01.
Article em En | MEDLINE | ID: mdl-35895381

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos